Medtronic and Philips, two global leaders in healthcare technology, announced a significant step forward in their strategic collaboration in patient monitoring, signing a multi-year partnership agreement focused on improving patient care and expanding access to technology.

Medtronic and Philips have a strong history of partnership in monitoring since 1992 and continue to work together to provide combined leading technologies for individual monitoring parameters.

The new strategic partnership agreement includes the integration of next-generation technologies from Medtronic into Philips’ monitoring solutions, providing a streamlined offering for healthcare providers. Philips' patient monitoring systems currently incorporate world-class Medtronic technology, including Nellcor™ pulse oximetry, Microstream™ capnography, and BIS™ brain monitoring. Under the new agreement, Philips will also bundle its essential supplies, including ECG, NIBP, and batteries, with Philips’ Medtronic-enabled monitors. This combined offering helps better meet the needs of clinicians around the globe through expanded equipment access to the latest technology and through joint training and education programs designed to improve patient care.

Reinforcing their dedication to high-quality, safe monitoring, the two companies are also establishing a pledge program. Both organizations believe using products that have been rigorously validated and tested on both parties' equipment is essential for ensuring patient safety.

“We’re proud to strengthen our collaboration with Medtronic, a partner that shares our commitment to expanding access to safe, reliable patient care,” said Sachin Chaudhari, vice president and general manager, Clinical Applications and Devices, Philips Hospital Patient Monitoring. “By providing a comprehensive monitoring solution that is validated throughout all stages, we’re supporting clinicians’ heavy workloads and complex patient cases by providing tools that can help address the daily challenges care teams face.”

With a shared commitment to enhancing patient care, the continued innovation that Medtronic is delivering — coupled with Philips’ market-leading monitoring solutions — will provide clinicians, patients, and caregivers greater insights and reliable monitoring.  

“Together with Philips, we are eager to continue to integrate next-generation technologies and leverage our combined global presence to empower healthcare professionals with world-class technology to personalize patient care, anytime, anywhere,” said Brian Blomerth, vice president of strategy operations and chief financial officer for the Acute Care & Monitoring business, which is part of the Medical Surgical Portfolio at Medtronic. “The patient monitoring technology from Philips already incorporates the market-leading Medtronic brands of Nellcor™ pulse oximetry, Microstream™ capnography, and BIS™ brain monitoring, and building on this foundation exemplifies our dedication to advancing innovation and enhancing patient care.”

About Philips

Royal Philips is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. In 2023, Philips generated sales of EUR 18.2 billion and employs approximately 69,100 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

About Medtronic

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit medtronic.com and follow Medtronic on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:
Pamela Lee
Communications
+1-303-218-8264

Ryan Weispfenning
Investor Relations
+1-763-505-4626